Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT
2024 · European Heart Journal - Cardiovascular Pharmacotherapy · 4 citations
https://doi.org/10.1093/ehjcvp/pvae030